ANALYSISApril 13, 2026
Should recreational marijuana be legalized nationwide?
Recreational marijuana remains federally illegal in the United States, classified as a Schedule I substance under the Controlled Substances Act, even as 24 states have legalized it for recreational use and 40 states for medical use. In December 2025, President Trump signed an executive order directing the attorney general to expeditiously complete the rescheduling of cannabis from Schedule I to Schedule III, but as of March 4, 2026, no rescheduling had been finalized. Multiple competing bills are active in Congress ranging from full federal legalization to anti-reform measures.
Nearly half the country already lives somewhere marijuana is legal recreationally — so is the federal prohibition just a law that's already lost, or the last guardrail keeping a public health crisis from going national?
Not familiar with this story? Get context →
Federalism versus federal legalization
C
Twenty-four states have already answered the legalization question through their own democratic processes, and federal legalization through something like the MORE Act would not be liberation — it would be a transfer of power from Sacramento and Denver to Washington. The conservative answer is narrow: get the federal government out of the way of states that have already acted, not replace federal prohibition with federal standardization.
L
The federalism framing sounds principled until you remember that AG Sessions rescinded the Cole Memorandum in 2018 with a single memo, leaving every state-legal business overnight vulnerable to federal prosecution. If 'let states decide' means 'until the next attorney general disagrees,' that is not a durable framework — it is a policy that can be revoked before lunch.
C
The Cole rescission is a real problem, and I will not minimize it — but the answer is narrow statutory protection, something like codifying the Cole framework, not full federal legalization with its accompanying tax and regulatory apparatus. The vulnerability is real; the conclusion that it requires handing Washington a national cannabis market does not follow.
L
A statute that protects state-legal activity without creating federal legalization is genuinely worth discussing — but every Congressional attempt at that narrow fix has stalled, while the exposure remains live. At some point 'narrow statutory protection in theory' has to answer for its absence in practice.
IRS 280E and banking access
C
IRS Section 280E, triggered by Schedule I status, denies cannabis businesses standard operating expense deductions available to every other legal industry — creating effective tax rates that can exceed 70% and push commerce toward untaxed black markets. That is not harm reduction or conservative governance; that is the administrative state punishing businesses that voters in 24 states explicitly chose to create.
L
The Lankford-Ricketts bill introduced in February 2025 would block cannabis businesses from deducting ordinary operating expenses even after rescheduling — meaning the punitive tax treatment would survive the very reform conservatives are proposing. That bill reveals the actual agenda with unusual clarity: this is not about health, it is about strangling legal markets that voters chose.
C
Lankford-Ricketts is bad policy and I will say so plainly — but one bad bill does not define the conservative position any more than one progressive overreach defines the liberal one. The correct response is to kill that bill and fix 280E, not to treat it as proof that only full federal legalization can produce fair tax treatment.
L
Fair enough that one bill is not the whole position — but 280E has been the law since 1982, banking access has been denied for decades, and the reform coalition that could fix both keeps losing to the same caucus backing Lankford-Ricketts. At some point the pattern is the position.
Racial enforcement disparity
C
The racial enforcement argument is serious and deserves a direct answer: Black Americans are arrested for cannabis possession at roughly four times the rate of white Americans despite comparable usage rates, and that disparity is a genuine indictment of how federal prohibition has operated. But the remedy for unequal enforcement is not necessarily federal legalization — it is ending the enforcement practices that produced the inequality.
L
Ending the enforcement practice is exactly what the MORE Act does, paired with expungement provisions for prior convictions. What the federalism-only approach cannot do is clear the records of people already convicted under federal law — only federal legislation reaches those cases. Telling someone their state decriminalized but their federal conviction stands is not a solution.
C
Expungement is a legitimate goal and can be pursued as standalone legislation without bundling it to full federal legalization and the regulatory apparatus that comes with it. The records problem is real and solvable without giving Washington a national cannabis market.
L
Standalone expungement has been proposed repeatedly and has gone nowhere, because the political coalition willing to clear those records is the same coalition pushing the MORE Act — they are not separable in practice, whatever the theory says.
Schedule I blocking medical research
C
Schedule I classification has specifically prevented rigorous federally-funded cannabis research for fifty years — it is the classification itself that has created the evidentiary gap that opponents then cite as a reason not to act. Trump's December 2025 executive order directing rescheduling to Schedule III is the correct move: it opens the research pipeline without committing to a national commercial framework.
L
Rescheduling to Schedule III is welcome, but it is worth noting that conservatives have had fifty years and a Schedule I classification that they mostly defended to fund the research they now say we need before acting. The uncertainty in the 2025 memory and cardiovascular studies is real — but it is an argument for faster federally-funded science, not for preserving the regime that produced the research gap in the first place.
C
That is a fair historical indictment, and Schedule III rescheduling is specifically the correction — it unlocks federal research funding while states continue operating as the laboratories the Constitution intended. That is not preserving the old regime; it is dismantling it at the right level.
L
Schedule III rescheduling is a genuine improvement, and I will credit it as such — but research that begins in 2026 will not produce settled science before millions more people are using a product whose safety profile remains incomplete. Regulated markets with potency labeling and product testing protect those people now; waiting for the science does not.
Black markets versus regulated access
C
California's persistent black market — thriving despite state legalization — is the cautionary tale here: when taxes and regulation make legal products noncompetitive, consumers go where the government cannot see them. Federal legalization would almost certainly replicate the high-tax, high-regulation model at national scale and make the black market problem worse, not better.
L
The California comparison proves too much — the black market problem there is an argument for smarter tax design, not against legalization itself. And the relevant comparison is not legal market versus a perfectly competitive black market. It is a regulated market with age verification and product testing versus a black market that checks neither. Federal legalization done right is harm reduction in the most literal sense.
C
Colorado's legal market, built under state design rather than federal mandate, has actually competed successfully against illicit alternatives — which is precisely the argument for letting states continue to calibrate their own tax and regulatory structures rather than imposing a federal model that could repeat California's mistakes at national scale.
L
Colorado works because Colorado controls its own design — agreed. But a federal framework does not have to mean federal uniformity; it can set a floor while leaving states to calibrate above it. The alternative, thirty states with no legal market and an active black market, is not a harm reduction success story either.
Conservative's hardest question
The federalism argument depends on stable federal non-enforcement, but the rescission of the Cole Memorandum by AG Sessions in 2018 proves that state-legal cannabis businesses remain permanently vulnerable to federal prosecution under any administration — meaning the 'let states decide' framework may be structurally unstable without some form of federal statutory protection that looks uncomfortably close to federal legalization.
Liberal's hardest question
The evidence on youth cannabis use in legalized states is genuinely mixed, and the 2025 studies linking heavy use to memory decline and cardiovascular risk introduce a legitimate public health uncertainty that federal legalization would scale nationally before the science is settled. A serious liberal argument has to sit with that discomfort rather than wave it away.
Both sides agree: Both sides agree that the Schedule I classification is scientifically indefensible and that it has specifically obstructed the federally-funded research needed to resolve the very health questions both sides cite as unsettled.
The real conflict: The core factual-and-values conflict is whether 'federal statutory protection for state-legal activity' and 'federal legalization' are meaningfully distinct outcomes: conservatives claim the STATES Act framework avoids federal regulatory capture while liberals argue any durable federal protection requires federal standards that functionally constitute legalization.
What nobody has answered: If the Schedule I classification is what has blocked rigorous cannabis research for fifty years, and both sides agree the health evidence is genuinely unsettled, what democratic or scientific basis exists for setting national policy — in either direction — before that research is conducted, and who bears the cost of the delay?
Sources
- Web search results provided: current U.S. state-level cannabis legalization status (2025-2026)
- Web search results provided: Trump December 2025 executive order on cannabis rescheduling
- Web search results provided: MORE Act reintroduction by Rep. Jerry Nadler, August 29, 2025
- Web search results provided: STATES 2.0 Act details and status
- Web search results provided: Lankford-Ricketts anti-deduction bill, February 7, 2025
- Web search results provided: Pew Research Center polling on marijuana legalization
- Web search results provided: New Hampshire HB 186 legislative timeline, January-February 2026
- Web search results provided: Colorado job creation data post-legalization
- Web search results provided: Montana THC cap legislation and Sen. Greg Hertz statements
- Web search results provided: 2025 health studies on marijuana and cardiovascular/memory risks